BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26639170)

  • 1. The Loudness Dependence of Auditory Evoked Potentials (LDAEP) in individuals at risk for developing bipolar disorders and schizophrenia.
    Hagenmuller F; Heekeren K; Meier M; Theodoridou A; Walitza S; Haker H; Rössler W; Kawohl W
    Clin Neurophysiol; 2016 Feb; 127(2):1342-1350. PubMed ID: 26639170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The loudness dependence of the auditory evoked potential (LDAEP) in schizophrenia, bipolar disorder, major depressive disorder, anxiety disorder, and healthy controls.
    Park YM; Lee SH; Kim S; Bae SM
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):313-6. PubMed ID: 20005279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity.
    Juckel G; Gallinat J; Riedel M; Sokullu S; Schulz C; Möller HJ; Müller N; Hegerl U
    Schizophr Res; 2003 Nov; 64(2-3):115-24. PubMed ID: 14613676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic dysfunction in the prodromal, first-episode and chronic course of schizophrenia as assessed by the loudness dependence of auditory evoked activity.
    Gudlowski Y; Ozgürdal S; Witthaus H; Gallinat J; Hauser M; Winter C; Uhl I; Heinz A; Juckel G
    Schizophr Res; 2009 Apr; 109(1-3):141-7. PubMed ID: 19268544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics associated with different strengths of loudness dependence of auditory evoked potentials (LDAEP) in major depressive disorder.
    Min JA; Lee SH; Lee SY; Chae JH; Lee CU; Park YM; Bae SM
    Psychiatry Res; 2012 Dec; 200(2-3):374-81. PubMed ID: 23021319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The loudness dependence of auditory evoked potentials and effects of psychopathology and psychopharmacotherapy in psychiatric inpatients.
    Ostermann J; Uhl I; Köhler E; Juckel G; Norra C
    Hum Psychopharmacol; 2012 Nov; 27(6):595-604. PubMed ID: 24446538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The loudness dependence of auditory evoked potentials (LDAEP) as an indicator of serotonergic dysfunction in patients with predominant schizophrenic negative symptoms.
    Wyss C; Hitz K; Hengartner MP; Theodoridou A; Obermann C; Uhl I; Roser P; Grünblatt E; Seifritz E; Juckel G; Kawohl W
    PLoS One; 2013; 8(7):e68650. PubMed ID: 23874705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loudness dependence of the auditory evoked N1/P2 component as an indicator of serotonergic dysfunction in patients with schizophrenia--a replication study.
    Juckel G; Gudlowski Y; Müller D; Ozgürdal S; Brüne M; Gallinat J; Frodl T; Witthaus H; Uhl I; Wutzler A; Pogarell O; Mulert C; Hegerl U; Meisenzahl EM
    Psychiatry Res; 2008 Feb; 158(1):79-82. PubMed ID: 18096246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for sex differences in the loudness dependence of the auditory evoked potential in humans.
    Oliva JL; Leung S; Croft RJ; O'Neill BV; Stout JC; Nathan PJ
    Hum Psychopharmacol; 2011 Mar; 26(2):172-6. PubMed ID: 21455974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the loudness dependence of auditory evoked potentials and age in patients with schizophrenia and depression.
    Jang KI; Kim S; Lee C; Chae JH
    J Int Med Res; 2022 Jul; 50(7):3000605221109789. PubMed ID: 35808808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining the underpinnings of loudness dependence of auditory evoked potentials with positron emission tomography.
    Pillai RLI; Bartlett EA; Ananth MR; Zhu C; Yang J; Hajcak G; Parsey RV; DeLorenzo C
    Neuroimage; 2020 Jun; 213():116733. PubMed ID: 32169543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the loudness dependence of auditory evoked potentials: single-electrode estimation versus dipole source analysis.
    Hagenmuller F; Hitz K; Darvas F; Kawohl W
    Hum Psychopharmacol; 2011 Mar; 26(2):147-54. PubMed ID: 21455973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loudness dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission: simultaneous electrophysiological recordings and in vivo microdialysis in the rat primary auditory cortex.
    Wutzler A; Winter C; Kitzrow W; Uhl I; Wolf RJ; Heinz A; Juckel G
    Neuropsychopharmacology; 2008 Dec; 33(13):3176-81. PubMed ID: 18463629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in central serotoninergic transmission among patients with recent onset, sub-chronic, and chronic schizophrenia as assessed by the loudness dependence of auditory evoked potentials.
    Park YM; Jung E; Kim HS; Hahn SW; Lee SH
    Schizophr Res; 2015 Oct; 168(1-2):180-4. PubMed ID: 26232871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Cortical GABA and Loudness Dependence of Auditory Evoked Potentials (LDAEP) in Humans.
    Wyss C; Tse DHY; Boers F; Shah NJ; Neuner I; Kawohl W
    Int J Neuropsychopharmacol; 2018 Sep; 21(9):809-813. PubMed ID: 29917080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loudness dependence of auditory evoked potentials (LDAEP) in clinical monitoring of suicidal patients with major depression in comparison with non-suicidal depressed patients and healthy volunteers: A follow-up-study.
    Graßnickel V; Illes F; Juckel G; Uhl I
    J Affect Disord; 2015 Sep; 184():299-304. PubMed ID: 26120809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of loudness dependence of auditory evoked potentials in patients with atypical depression.
    Lee SH; Park YC; Yoon S; Kim JI; Hahn SW
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():7-12. PubMed ID: 24865151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loudness- and time-dependence of auditory evoked potentials is blunted by the NMDA channel blocker MK-801.
    Teichert T
    Psychiatry Res; 2017 Oct; 256():202-206. PubMed ID: 28645081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preserved Serotonergic Activity in Early-Onset Parkinson's Disease.
    Park HK; Lee JJ; Park YM
    Can J Neurol Sci; 2020 May; 47(3):344-349. PubMed ID: 31685057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insights in the central serotonergic function in patients with affective disorders].
    Kawohl W; Hegerl U; Müller-Oerlinghausen B; Juckel G
    Neuropsychiatr; 2008; 22(1):23-7. PubMed ID: 18381053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.